Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.
about
Prophylactic mastectomy for the prevention of breast cancerA Systematic Review of Clinical Outcomes and Prognostic Factors for Patients Undergoing Surgery for Spinal Metastases Secondary to Breast CancerHigh Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to PaclitaxelClinical management of women with metastatic breast cancer: a descriptive study according to age group.FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy.Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer.SZ-685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt/FOXO pathwayBreast cancer subtypes predict the preferential site of distant metastases: a SEER based studyCTMP, a predictive biomarker for trastuzumab resistance in HER2-enriched breast cancer patientSignificant survival improvement of patients with recurrent breast cancer in the periods 2001-2008 vs. 1992-2000.Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study.Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatment.miR-320a is an independent prognostic biomarker for invasive breast cancerBrain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of deathCost Effectiveness of Exemestane versus Tamoxifen in Post-Menopausal Women with Early Breast Cancer in Germany.Prognostic value of poorly differentiated clusters in invasive breast cancer.Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma.The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.Predicting survival of de novo metastatic breast cancer in Asian women: systematic review and validation study.Prognostic value of osteopontin expression in breast cancer: A meta-analysis.Defining the survival benchmark for breast cancer patients with systemic relapseSurvival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval.An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients.ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer.Clinicopathologic characteristics and prognostic factors for HER2-positive patients with metastatic breast cancer in southern China.Prognostic value of receptor conversion after neoadjuvant chemotherapy in breast cancer patients: a prospective observational study.Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy.Letrozole in advanced breast cancer: the PO25 trial.The potential of proton beam radiation for palliation and reirradiation.Metastasis-Free Interval Is Closely Related to Tumor Characteristics and Has Prognostic Value in Breast Cancer Patients with Distant Relapse.Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancerIn silico discovery of mitosis regulation networks associated with early distant metastases in estrogen receptor positive breast cancers.MRI kinetics with volumetric analysis in correlation with hormonal receptor subtypes and histologic grade of invasive breast cancersPrognostic value of FDG PET/CT-based metabolic tumor volumes in metastatic triple negative breast cancer patientsThe impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis.Estrogen receptor and breast MR imaging features: a correlation study.Prognostic factors for patients with bone-only metastasis in breast cancerRelation between primary tumor FDG avidity and site of first distant metastasis in patients with breast cancer.Ixabepilone for the treatment of taxane-refractory breast cancer.
P2860
Q24236609-6D6D56AD-25BF-4079-BB11-7EB86E3384E1Q26738942-59780E1A-4A3A-4D77-88C5-0DBFC75FEFA6Q28548522-90300514-F0AE-46F7-A83D-F58F7E4226D6Q33249084-908D011E-D376-4349-8C11-75783BE05631Q33320890-CAF2310F-DA82-4F2A-8323-5FD3732732EFQ33338630-5D73B7D1-68E3-42A7-A316-F9E7CBF48486Q33685963-411FA655-ED33-4F0D-9163-34F9A10DC6ADQ33709532-9E8D449F-1CB6-45B3-9ADC-D42DA6D96E6EQ33728102-C88CDC99-C932-408A-872C-9C4BC7359F94Q33858930-FF33B6D6-ADF1-4323-A2F1-93DA4EEE328AQ33874796-20781C09-A8C2-4664-A823-CE769126B19DQ33878643-E41B290A-5133-49BD-B84D-73331352D8D4Q33953465-B7435DFB-A2A1-442A-8CFC-9A13C7DFE2C2Q33967807-6C0D4A53-6542-486A-84A3-15CF8947DAFCQ34022312-7AA9B64B-C093-46A4-A11E-B70E4069F62BQ34140072-8260DF05-4066-42CA-B8AA-558E60FF931EQ34409852-A11A60D7-6451-45CD-A65F-F66B12E8CDACQ34633934-96D3F0A5-C45A-4FDB-8F36-F5FE287FB9F9Q35052176-C78B3BF4-B07F-4D63-A57B-5095710CD9A3Q35138699-3C741864-A8DD-4098-A5D1-68C58FDF92DCQ35179993-6BB702D9-583A-4A36-8327-0722901F00CCQ35459288-07FED5CD-F0D8-4949-BBDE-CB9B67A055E1Q35573228-E0F22140-F5D0-4EAE-B6AF-AFB6D90B4B12Q35611844-9F1A61C5-C209-41C6-8B91-E8E76EA3439EQ35620279-52DC8051-0DFD-4C29-8AEE-7EC7FEB0E64FQ35829230-0E486AF0-B309-4566-AAC2-A5CB20B5523DQ35832458-F04B579B-1471-4BBF-9DDA-880806E9EC26Q35894728-4C8F6FE4-B36D-4A77-930C-D110F0D671E8Q36026424-B20A9BD9-5073-4FD4-9F7E-916C269C1370Q36333029-BFC04CD3-F88E-43A1-AF44-E758D1B717C8Q36441543-D42885AE-725E-492B-91C2-E5FC51D66AC3Q36614929-462BD48F-0851-43CA-854A-2BAFB547BC08Q36629870-4F0698E1-D001-4233-AA6F-4C1B50E6A956Q36853113-57F64C71-E8A1-4CF0-B6A9-532A54FC4FFDQ36874902-9846FC93-3E91-434D-ADF0-A63FA0718CD5Q37031974-B766F48E-2BBD-4A74-BBAF-5B2864B8502FQ37035974-13F5CB33-DC46-4626-8B56-FB108C8513D0Q37094622-3F9E00B8-D5BE-4759-B8DA-F5699A0F51D6Q37175888-C559E6DB-84F7-4C69-8265-2DFFD6F5A824Q37179381-FDB78973-4C5B-4F42-8D67-E4109F6AE801
P2860
Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Survival of patients with meta ...... markers of the primary tumor.
@en
Survival of patients with meta ...... markers of the primary tumor.
@nl
type
label
Survival of patients with meta ...... markers of the primary tumor.
@en
Survival of patients with meta ...... markers of the primary tumor.
@nl
prefLabel
Survival of patients with meta ...... markers of the primary tumor.
@en
Survival of patients with meta ...... markers of the primary tumor.
@nl
P2093
P356
P1433
P1476
Survival of patients with meta ...... c markers of the primary tumor
@en
P2093
D Craig Allred
Gary Chamness
Gary M Clark
Richard M Elledge
Syed Mohsin
P304
P356
10.1002/CNCR.11083
P407
P577
2003-02-01T00:00:00Z